Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment

被引:79
作者
Ogilvy, S [1 ]
Elefanty, AG [1 ]
Visvader, J [1 ]
Bath, ML [1 ]
Harris, AW [1 ]
Adams, JM [1 ]
机构
[1] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
关键词
D O I
10.1182/blood.V91.2.419.419_419_430
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vav gene is expressed in all hematopoietic but few other cell types. To explore its unusual compartment-wide regulation, We cloned the murine gene, sequenced its promoter region, identified DNase I hypersensitive (HS) sites in the chromatin, and tested their promoter activity with a beta-galactosidase (beta-gal) reporter gene in cell lines and transgenic mice. Whereas fibroblasts had no HS sites, a myeloid and an erythroid cell line contained five, located 0.2 kb (HS1), 1.9 kb (HS2), and 3.6 kb (HS3) upstream from the transcription start and 0.6 kb (HS4) and 10 kb (HS5) downstream. A vav DNA fragment including HS1 promoted beta-gal expression in a myeloid but not a fibroblast line. Expression in leukocytes of transgenic mice also required HS2 and HS5. Only hematopoietic organs contained beta-gal, but virtually all beta-gal(+) cells were B or T lymphocytes. Expression was always variegated (mosaic), and the proportion of beta-gal(+) cells declined with lymphoid maturation and animal age. Thus, these vav regulatory elements promoted hematopoietic-specific expression in vivo, at least in lymphocytes, but the transgene was sporadically silenced. Maintaining pan-hematopoietic expression may require additional vav elements or an alternative reporter. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:419 / 430
页数:12
相关论文
共 46 条
  • [31] SELECTIVE TARGETING OF GENE-PRODUCTS WITH THE MEGAKARYOCYTE PLATELET FACTOR-IV PROMOTER
    RAVID, K
    BEELER, DL
    RABIN, MS
    RULEY, HE
    ROSENBERG, RD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) : 1521 - 1525
  • [32] Age-dependent silencing of globin transgenes in the mouse
    Robertson, G
    Garrick, D
    Wilson, M
    Martin, DIK
    Whitelaw, E
    [J]. NUCLEIC ACIDS RESEARCH, 1996, 24 (08) : 1465 - 1471
  • [33] POSITION-DEPENDENT VARIEGATION OF GLOBIN TRANSGENE EXPRESSION IN MICE
    ROBERTSON, G
    GARRICK, D
    WU, WL
    KEARNS, M
    MARTIN, D
    WHITELAW, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5371 - 5375
  • [34] ROEDERER M, 1991, Methods (Orlando), V2, P248, DOI 10.1016/S1046-2023(05)80067-2
  • [35] METAL-BINDING FINGER STRUCTURES IN THE GLUCOCORTICOID RECEPTOR DEFINED BY SITE-DIRECTED MUTAGENESIS
    SEVERNE, Y
    WIELAND, S
    SCHAFFNER, W
    RUSCONI, S
    [J]. EMBO JOURNAL, 1988, 7 (08) : 2503 - 2508
  • [36] SHORTMAN K, 1972, Journal of Immunological Methods, V1, P273, DOI 10.1016/0022-1759(72)90005-1
  • [37] BCL-2 TRANSGENE INHIBITS T-CELL DEATH AND PERTURBS THYMIC SELF-CENSORSHIP
    STRASSER, A
    HARRIS, AW
    CORY, S
    [J]. CELL, 1991, 67 (05) : 889 - 899
  • [38] A globin enhancer acts by increasing the proportion of erythrocytes expressing a linked transgene
    Sutherland, HGE
    Martin, DIK
    Whitelaw, E
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (03) : 1607 - 1614
  • [39] SR-ALPHA PROMOTER - AN EFFICIENT AND VERSATILE MAMMALIAN CDNA EXPRESSION SYSTEM COMPOSED OF THE SIMIAN VIRUS-40 EARLY PROMOTER AND THE R-U5 SEGMENT OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 LONG TERMINAL REPEAT
    TAKEBE, Y
    SEIKI, M
    FUJISAWA, JI
    HOY, P
    YOKOTA, K
    ARAI, KI
    YOSHIDA, M
    ARAI, N
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (01) : 466 - 472
  • [40] DEFECTIVE ANTIGEN RECEPTOR-MEDIATED PROLIFERATION OF B-CELLS AND T-CELLS IN THE ABSENCE OF VAV
    TARAKHOVSKY, A
    TURNER, M
    SCHAAL, S
    MEE, PJ
    DUDDY, LP
    RAJEWSKY, K
    TYBULEWICZ, VLJ
    [J]. NATURE, 1995, 374 (6521) : 467 - 470